Creating a new facility to enhance research on dangerous infectious diseases
Developing the VUMC MICRO facility to advance innovative BSL3 research
This study is working to create a top-notch research facility at Vanderbilt University Medical Center that will help scientists safely study dangerous germs and develop new treatments and vaccines, especially for serious infections like COVID-19, so they can work together with other local institutions to better tackle these health challenges.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10596928 on NIH RePORTER |
What this research studies
This research aims to establish a state-of-the-art biosafety level 3 (BSL3) facility at Vanderbilt University Medical Center to support advanced studies on highly virulent pathogens. The facility will enable researchers to conduct critical investigations into microbial pathogenesis, therapeutic development, and vaccine design, particularly in response to the growing threat of infectious diseases like COVID-19. By expanding access to BSL3 research capabilities, the project will foster collaboration among regional institutions and enhance the overall capacity for infectious disease research in the southeastern United States.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases or those at high risk of exposure to such pathogens.
Not a fit: Patients with non-infectious diseases or those not at risk for infectious disease exposure may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in the understanding and treatment of infectious diseases, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown success in enhancing BSL3 facilities to improve infectious disease research, indicating that this approach is both viable and necessary.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Skaar, Eric P — Vanderbilt University Medical Center
- Study coordinator: Skaar, Eric P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.